{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:27:15Z","timestamp":1793330835087,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018747","name":"SkylineDx BV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.critrevonc.2025.104816","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T19:30:14Z","timestamp":1750447814000},"page":"104816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Predictive performance of the clinicopathologic gene expression profile (CP-GEP) in identifying cutaneous melanoma patients for whom sentinel lymph node biopsy is unnecessary: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"214","author":[{"given":"Terence","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Ch\u2019ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas Pires da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serigne N.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.critrevonc.2025.104816_bib1","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","article-title":"Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?","volume":"17","author":"van Akkooi","year":"2006","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104816_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104816_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/SAP.0000000000001152","article-title":"Identification of risk factors in lymphatic surgeries for melanoma: a national surgical quality improvement program review","volume":"79","author":"Ascha","year":"2017","journal-title":"Ann. Plast. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104816_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1245\/s10434-015-4766-y","article-title":"Identification of patients with intermediate thickness melanoma at low risk for sentinel lymph node positivity","volume":"23","author":"Bartlett","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104816_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/PO.19.00206","article-title":"Model combining tumor molecular and clinicopathologic risk factors predicts sentinel lymph node metastasis in primary cutaneous melanoma","author":"Bellomo","year":"2020","journal-title":"JCO Precis. Oncol."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104816_bib6","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-15-2461","article-title":"Lysyl oxidase (LOX) transcriptionally regulates SNAI2 expression and TIMP4 secretion in human cancers","volume":"22","author":"Boufraqech","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104816_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58111589","article-title":"Sentinel lymph node biopsy in cutaneous melanoma, a clinical point of view","volume":"58","author":"Br\u0103ni\u015fteanu","year":"2022","journal-title":"Medicina"},{"issue":"6470","key":"10.1016\/j.critrevonc.2025.104816_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/368419a0","article-title":"Physiological consequences of loss of plasminogen activator gene function in mice","volume":"368","author":"Carmeliet","year":"1994","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104816_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamaoncol.2022.0134","article-title":"Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US From 2010 to 2018","volume":"8","author":"Chen","year":"2022","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104816_bib10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4161\/19336918.2014.972788","article-title":"Extracellular matrix as a contextual determinant of transforming growth factor-\u03b2 signaling in epithelial-mesenchymal transition and in cancer","volume":"8","author":"Cichon","year":"2014","journal-title":"Cell Adhes. Migr."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104816_bib11","doi-asserted-by":"crossref","DOI":"10.2217\/mmt-2019-0018","article-title":"Increase of sentinel lymph node melanoma staging in the Netherlands; still room and need for further improvement","volume":"7","author":"Deckers","year":"2020","journal-title":"Melanoma Manag."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104816_bib12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant Pembrolizumab versus Placebo in Resected Stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104816_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.19895","article-title":"Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort*","volume":"185","author":"El Sharouni","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104816_bib14","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-019-07204-2","article-title":"Trends in sentinel lymph node biopsy enactment for cutaneous melanoma","volume":"26","author":"El Sharouni","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104816_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4081\/oncol.2019.433","article-title":"Evolving management of positive regional lymph nodes in melanoma: past, present and future directions","volume":"13","author":"Fayne","year":"2019","journal-title":"Oncol. Rev."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104816_bib16","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-11-0156","article-title":"IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells","volume":"71","author":"Fernando","year":"2011","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104816_bib17","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104816_bib18","doi-asserted-by":"crossref","first-page":"14006","DOI":"10.1074\/jbc.M413692200","article-title":"MART-1 is required for the function of the melanosomal matrix protein PMEL17\/GP100 and the maturation of melanosomes","volume":"280","author":"Hoashi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104816_bib19","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1245\/s10434-020-08558-8","article-title":"Sentinel lymph node biopsy for T1b melanoma: balancing prognostic value and cost","volume":"27","author":"Hu","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104816_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jso.25208","article-title":"Sentinel lymph node biopsy in patients with thin melanomas: frequency and predictors of metastasis based on analysis of two large international cohorts","volume":"118","author":"Isaksson","year":"2018","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104816_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejso.2021.11.010","article-title":"Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary","volume":"48","author":"Johansson","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104816_bib22","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/emboj\/20.7.1663","article-title":"Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice","volume":"20","author":"Larsson","year":"2001","journal-title":"Embo J."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104816_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18632\/oncotarget.6205","article-title":"GDF15 promotes EMT and metastasis in colorectal cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104816_bib24","doi-asserted-by":"crossref","unstructured":"Lo, S.N., Gjorup, C., Chakera, A.H., H\u00f6lmich, L.R., Moncrieff, M., MacKenzie Ross, A., Cassell, O., Ma, J., Weitemeyer, M.B., Bagge, R.O., Klausen, S., Calsavara, V.F., Duprat Neto, J.P., Bertolli, E., Ch'ng, S., Saw, R.P.M., Shannon, K.F., Spillane, A.J., Nieweg, O.E., Stretch, J.R., Mann, G.J., Geh, J.L.C., Haydu, L.E., Martin, R.C.W., Sharon, C., Karakousis, G.C., Kashani-Sabet, M., Adigbli, G., El Sharouni, M.A., Gershenwald, J.E., Scolyer, R.A., Thompson, J.F., Varey, A.H.R., 2025. Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma. JAMA Dermatol.","DOI":"10.1001\/jamadermatol.2025.0318"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104816_bib25","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1200\/JCO.19.02362","article-title":"Improved risk prediction calculator for sentinel node positivity in patients with melanoma: the melanoma institute Australia Nomogram","volume":"38","author":"Lo","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104816_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamadermatol.2025.0113","article-title":"Risk prediction models for sentinel node positivity in melanoma: a systematic review and meta-analysis","volume":"161","author":"Ma","year":"2025","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104816_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/pr900907g","article-title":"Extracellular remodelling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration","volume":"9","author":"Mathias","year":"2010","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104816_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/SLA.0b013e3181b07ffd","article-title":"Sentinel node status prediction by four statistical models: results from a large bi-institutional series (n = 1132)","volume":"250","author":"Mocellin","year":"2009","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104816_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","article-title":"Complications of sentinel lymph node biopsy for melanoma - a systematic review of the literature","volume":"43","author":"Moody","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104816_bib30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104816_bib31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/bjd.19499","article-title":"Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma","volume":"184","author":"Mulder","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.critrevonc.2025.104816_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fmed.2019.00231","article-title":"The role and necessity of sentinel lymph node biopsy for invasive melanoma","volume":"6","author":"Nakamura","year":"2019","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104816_bib33","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1245\/s10434-008-0077-x","article-title":"Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma","volume":"15","author":"Pi\u00f1ero","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104816_bib34","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","author":"Riley","year":"2024","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104816_bib35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1468-3083.2011.04181.x","article-title":"Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study","volume":"26","author":"Savoia","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104816_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ije\/dyp370","article-title":"Forest plots in reports of systematic reviews: a cross-sectional study reviewing current practice","volume":"39","author":"Schriger","year":"2010","journal-title":"Int. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104816_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107249","article-title":"Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: a multicenter prospective Dutch study","volume":"49","author":"Stassen","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104816_bib38","article-title":"Redesigning sentinel lymph node biopsy guidelines in melanoma cases","volume":"23","author":"Stetkevich","year":"2023","journal-title":"Eplasty"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104816_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/cancers16030583","article-title":"The use of gene expression profiling and biomarkers in melanoma diagnosis and predicting recurrence: implications for surveillance and treatment","volume":"16","author":"Sun","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104816_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/ijd.16515","article-title":"Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis","volume":"62","author":"Thao","year":"2023","journal-title":"Int. J. Dermatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104816_bib41","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1245\/s10434-017-5890-7","article-title":"Poor adherence to National Clinical Management guidelines: a population-based, cross-sectional study of the surgical management of melanoma in New South Wales, Australia","volume":"24","author":"Varey","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104816_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice guideline update","volume":"36","author":"Wong","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104816_bib43","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1245\/ASO.2005.05.016","article-title":"A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system","volume":"12","author":"Wong","year":"2005","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104816_bib44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11845-014-1166-4","article-title":"Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population","volume":"184","author":"Woods","year":"2015","journal-title":"Ir. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104816_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70011","article-title":"iMLGAM: integrated Machine Learning and Genetic Algorithm-driven Multiomics analysis for pan-cancer immunotherapy response prediction","volume":"4","author":"Ye","year":"2025","journal-title":"Imeta"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104816_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/biof.2142","article-title":"Navigating the immune landscape with plasma cells: a pan-cancer signature for precision immunotherapy","volume":"51","author":"Ye","year":"2025","journal-title":"BioFactors"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104816_bib47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/ijd.15594","article-title":"Validation of CP-GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: a U.S. cohort study","volume":"60","author":"Yousaf","year":"2021","journal-title":"Int. J. Dermatol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:12:44Z","timestamp":1758589964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"alternative-id":["S1040842825002045"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104816","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive performance of the clinicopathologic gene expression profile (CP-GEP) in identifying cutaneous melanoma patients for whom sentinel lymph node biopsy is unnecessary: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104816"}}